HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study.

AuthorsSham Mailankody, Meghan Salcedo, Elizabet Tavitian, Miranda Burge, Neha Korde, Hani Hassoun, Alexander Lesokhin, Oscar Lahoud, Eric Smith, Malin Hultcrantz, Carlyn Tan, Urvi Shah, Sean Devlin, Ola Landgren
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 63 Issue 11 Pg. 2760-2761 (11 2022) ISSN: 1029-2403 [Electronic] United States
PMID35838493 (Publication Type: Letter, Research Support, N.I.H., Extramural)
Chemical References
  • ixazomib
  • Boron Compounds
  • Dexamethasone
Topics
  • Humans
  • Smoldering Multiple Myeloma
  • Pilot Projects
  • Boron Compounds (adverse effects)
  • Dexamethasone (adverse effects)
  • Multiple Myeloma (diagnosis, drug therapy)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: